Joel David Mayersohn

This profile gathers the share dealings of Joel David Mayersohn in Citius Oncology, Inc. Over a trading history stretching from 28 July 2025 to 19 September 2025, the count stands at 4 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 22 December 2025: a share grant, in Citius Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 42 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.